Penumbra PE Ratio 2014-2019 | PEN
Current and historical p/e ratio for Penumbra (PEN) from 2014 to 2019. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Penumbra PE ratio as of July 19, 2019 is 259.03.
| Penumbra PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2019-07-19 | 176.14 | 587.13 | |
| 2019-03-31 | 147.01 | $0.30 | 490.03 |
| 2018-12-31 | 122.20 | $0.15 | 814.67 |
| 2018-09-30 | 149.70 | $0.22 | 680.45 |
| 2018-06-30 | 138.15 | $0.78 | 177.12 |
| 2018-03-31 | 115.65 | $0.36 | 321.25 |
| 2017-12-31 | 94.10 | $0.11 | 855.45 |
| 2017-09-30 | 90.30 | $-0.22 | 0.00 |
| 2017-06-30 | 87.75 | $-0.27 | 0.00 |
| 2017-03-31 | 83.45 | $-0.21 | 0.00 |
| 2016-12-31 | 63.80 | $-0.09 | 0.00 |
| 2016-09-30 | 75.99 | $0.04 | 1899.75 |
| 2016-06-30 | 59.50 | $0.11 | 540.91 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $6.119B | $0.445B |
| Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access System, BENCHMARK Intracranial Access System, Penumbra System, 3D, Penumbra Coil 400, Penumbra SMART Coil and LIBERTY stent. Peripheral vascular products include Ruby Coil System, Penumbra Occlusion Device and Indigo System. It operates primarily in U.S., Europe, Canada and Australia. Penumbra, Inc. is headquartered in Alameda, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $115.922B | 25.36 |
| Intuitive Surgical (ISRG) | United States | $61.051B | 53.31 |
| Edwards Lifesciences (EW) | United States | $40.518B | 40.49 |
| IDEXX Laboratories (IDXX) | United States | $24.496B | 64.26 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $23.093B | 15.17 |
| Teleflex (TFX) | United States | $15.464B | 33.50 |
| Olympus (OCPNY) | Japan | $15.120B | 113.13 |
| SONOVA HOLDING (SONVY) | Switzerland | $14.591B | 0.00 |
| Sysmex ADR (SSMXY) | Japan | $14.533B | 39.18 |
| DexCom (DXCM) | United States | $13.892B | 272.46 |
| Hologic (HOLX) | United States | $12.939B | 20.81 |
| STERIS (STE) | Ireland | $12.366B | 29.91 |
| Varian Medical Systems (VAR) | United States | $12.078B | 30.81 |
| ABIOMED (ABMD) | United States | $11.795B | 71.75 |
| Masimo (MASI) | United States | $8.182B | 50.13 |
| SARTORIUS AG (SARTF) | Germany | $5.850B | 51.98 |
| Elekta AB (EKTAY) | Sweden | $5.087B | 38.33 |
| Integra LifeSciences Holdings (IART) | United States | $4.653B | 21.86 |
| Globus Medical (GMED) | United States | $4.220B | 26.31 |
| Tandem Diabetes Care (TNDM) | United States | $3.752B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $3.543B | 23.09 |
| Wright Medical Group (WMGI) | Netherlands | $3.423B | 678.50 |
| Cantel Medical (CMD) | United States | $3.306B | 33.54 |
| Glaukos (GKOS) | United States | $2.735B | 0.00 |
| Integer Holdings (ITGR) | United States | $2.652B | 19.54 |
| Nihon Kohden (NHNKY) | Japan | $2.401B | 24.16 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.903B | 30.11 |
| Nevro (NVRO) | United States | $1.882B | 0.00 |
| Inogen (INGN) | United States | $1.287B | 28.48 |
| Silk Road Medical (SILK) | United States | $1.279B | 0.00 |
| OPKO Health (OPK) | United States | $1.274B | 0.00 |
| Veracyte (VCYT) | United States | $1.243B | 0.00 |
| CryoLife (CRY) | United States | $1.123B | 111.37 |
| Accelerate Diagnostics (AXDX) | United States | $1.017B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $1.009B | 148.86 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.963B | 27.90 |
| ViewRay (VRAY) | United States | $0.915B | 0.00 |
| Luminex (LMNX) | United States | $0.897B | 117.35 |
| Natus Medical (BABY) | United States | $0.893B | 20.67 |
| Mesa Laboratories (MLAB) | United States | $0.878B | 41.29 |
| Pacific Biosciences Of California (PACB) | United States | $0.814B | 0.00 |
| Fluidigm (FLDM) | United States | $0.793B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.789B | 25.84 |
| AxoGen (AXGN) | United States | $0.756B | 0.00 |
| Quotient (QTNT) | Switzerland | $0.692B | 0.00 |
| Intersect ENT (XENT) | United States | $0.641B | 0.00 |
| Corindus Vascular Robotics (CVRS) | United States | $0.552B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.511B | 0.00 |
| Si-Bone (SIBN) | United States | $0.485B | 0.00 |
| GenMark Diagnostics (GNMK) | United States | $0.351B | 0.00 |
| Accuray (ARAY) | United States | $0.350B | 0.00 |
| Oxford Immunotec Global (OXFD) | United Kingdom | $0.350B | 18.76 |
| Semler Scientific (SMLR) | United States | $0.312B | 61.99 |
| RTI Surgical (RTIX) | United States | $0.303B | 37.27 |
| TransEnterix (TRXC) | United States | $0.302B | 0.00 |
| SeaSpine Holdings (SPNE) | United States | $0.241B | 0.00 |
| Neuronetics (STIM) | United States | $0.228B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.210B | 0.00 |
| ConforMIS (CFMS) | United States | $0.209B | 0.00 |
| IRadimed (IRMD) | United States | $0.204B | 38.89 |
| CRH Medical (CRHM) | Canada | $0.198B | 68.50 |
| Sientra (SIEN) | United States | $0.172B | 0.00 |
| Stereotaxis (STXS) | United States | $0.166B | 0.00 |
| Second Sight Medical Products (EYES) | United States | $0.112B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.087B | 0.00 |
| Vermillion (VRML) | United States | $0.075B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.075B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.073B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.071B | 0.00 |
| Apollo Endosurgery (APEN) | United States | $0.066B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.064B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.055B | 0.00 |
